Nanomaterials for Photothermal Therapy and Antibacterial Applications
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (20 May 2022) | Viewed by 4645
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer and bacterial infectious disease have attracted considerable public attention due to their great threat to human health. In recent years, photothermal therapy (PTT) has been the object of growing interest, has undergone technological advances, and has been recognized as a non-invasive method to kill cancer cells and pathogenic bacteria. PTT requires the use of nanomaterials (e.g., gold nanoparticles, carbon nanomaterials, iron oxide nanoparticles, etc.) that exhibit high absorption in the near-infrared (NIR) region of the electromagnetic spectrum. The benefits of using nanomaterials is that the NIR light can be absorbed and rapidly converted into heat, thus increasing the surrounding temperature of the irradiated organisms.
We are launching a Special Issue of Nanomaterials entitled “Nanomaterials for Photothermal Therapy and Antibacterial Applications”. This Special Issue aims to cover different strategies against cancer and bacteria, improving the effect of phototherapy. We are particularly interested in the design of nanomaterials, and in the effects of their physico-chemical properties on their photothermal therapeutic efficiency in treating cancers and bacterial infections. We invite investigators to contribute review and original research papers reporting recent efforts in the field of nanomaterial-based photothermal therapies and antibacterial applications.
Dr. Chia-Hua Lin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nanomaterials
- Photothermal therapy
- Antibacterial
- Anticancer
- Nanotherapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
